Cardiomyopathy associated with high-dose interleukin-2 therapy.
AUTOR(ES)
Beck, A. C.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1002997Documentos Relacionados
- Acute pancreatitis associated with high-dose interleukin-2 immunotherapy for malignant melanoma.
- Peripheral neuropathy during longterm high-dose amiodarone therapy.
- Serum Vascular Endothelial Growth Factor and Fibronectin Predict Clinical Response to High-Dose Interleukin-2 Therapy
- Effect of saturable clearance during high-dose mezlocillin therapy.
- Intermittent high-dose vitamin C therapy in patients with HTLV-I associated myelopathy.